Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Dermatologic 37Thoracic 7Genitourinary 6Breast 6Gastrointestinal 5Head & Neck 4Sarcoma 2Lymphoid 2CNS 2Other hematologic neoplasm 1Gynecologic 1

Conditions

Head and Neck Neoplasms 193Squamous Cell Carcinoma of Head and Neck 171Oropharyngeal Neoplasms 35Carcinoma, Squamous Cell 26Nasopharyngeal Carcinoma 24Laryngeal Neoplasms 21Mouth Neoplasms 20Radiation Injuries 15Nasopharyngeal Neoplasms 12Hypopharyngeal Neoplasms 12Salivary Gland Neoplasms 11Xerostomia 8Neoplasms 8Mucositis 7Laryngeal Diseases 7Tongue Neoplasms 6Esthesioneuroblastoma, Olfactory 6Carcinoma, Non-Small-Cell Lung 6Carcinoma 6Thyroid Neoplasms 5Lung Neoplasms 5Recurrence 4Prostatic Neoplasms 4Melanoma 4Breast Neoplasms 4Thyroid Carcinoma, Anaplastic 3Rectal Neoplasms 3Pharyngeal Neoplasms 3Paranasal Sinus Neoplasms 3Pancreatic Neoplasms 3

Interventions

pembrolizumab 73Nivolumab 27atezolizumab 15Docetaxel 10Cyclophosphamide 10cemiplimab 9Ipilimumab 9Paclitaxel 8Interleukin-2 8Biopsy 7fludarabine 6durvalumab 6avelumab 6Taxes 6Specimen Handling 6epacadostat 5Magnetic Resonance Spectroscopy 5Immune Checkpoint Inhibitors 5Gemcitabine 5Drug Therapy 5Cisplatin 5Carboplatin 5spartalizumab 4Radiotherapy 4Radiosurgery 4Pemetrexed 4Cetuximab 4utomilumab 3trametinib 3poly ICLC 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Melanoma × Radiotherapy × Head & Neck × Clear all
NCT03474497 2026-01-29

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

University of California, Davis

Phase 1/2 Active not recruiting
18 enrolled 13 charts
DermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

NCT02318771 2025-05-15

Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer

Thomas Jefferson University

Phase 1 Completed
41 enrolled
DermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Renal Cell, Lung Neoplasms, Melanoma

NCT00405405 2025-05-06

Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer

Thomas Jefferson University

Phase 1 Completed
13 enrolled
DermatologicHead & Neck

Head and Neck Neoplasms, Melanoma, Parotid Neoplasms, Thyroid Neoplasms

NCT04435964 2023-03-24

G-DEFINER

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Completed
247 enrolled
BreastDermatologicHead & NeckThoracic

Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡